Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.
about
Trial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyClassification of current anticancer immunotherapiesExpression of Th17 cell population regulatory cytokines in laryngeal carcinoma - Preliminary studyOncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.Oncolytic Immunotherapy for Treatment of Cancer.Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.Antagonistic effects of selenium on cadmium-induced apoptosis by restoring the mitochondrial dynamic equilibrium and energy metabolism in chicken spleens.High frequency of activated NKp46(+) natural killer cells in patients with new diagnosed of latent autoimmune diabetes in adults.Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.NF-kappaB: Two Sides of the Same Coin.IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.
P2860
Q27021951-F489F4D8-EC9C-4A81-A929-1E2A9B72C507Q28072347-7F090601-B932-430E-A43F-561C68813A1DQ35149637-FD45A8B9-29A0-4640-B64D-AAEDA23E7C85Q36243933-953CD33E-6AC4-4F1B-81C4-2E8134277441Q37706248-33601218-8E1D-4DCC-A2AF-4EA9F2A51485Q38848223-A0504A2E-E0D4-4F90-9AEB-055AECE408DBQ40438006-7E6AB6A7-B998-4806-9FEE-A7FE34D54FE4Q40695075-8C75727C-F9BC-4E76-8070-9E3506BE4BF7Q41592828-DDE14134-4D41-4155-BE96-18306C137804Q41704358-8A13765F-4514-403E-BB74-B6025EC2BF8FQ42376411-BE66813C-D880-48BD-86CF-E942F9F46394Q45324119-72A1C1E5-C585-4E48-9C7A-241BE38CE39CQ47556651-2E98F2B2-D30B-4B33-8D70-1F3B6DF7895EQ52719969-5B01B5E9-F5C6-43A1-80C5-CE7413DA6A58Q55509278-6C8A6C73-29EA-4157-9F62-2C62B0927899
P2860
Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.
@en
type
label
Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.
@en
prefLabel
Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.
@en
P2093
P2860
P1433
P1476
Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0067512
P407
P50
P577
2013-07-03T00:00:00Z